# Determinants of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease.

> **NIH NIH K01** · UNIVERSITY OF PENNSYLVANIA · 2021 · $70,470

## Abstract

COVID-19 Related Disruption Summary
Dr. Johnson is a current Mentored Career Development Grant recipient, K01HL1359, in the final
year of her award. This disruption statement outlines the specific COVID-19 pandemic-related
interruptions to the conduct of Dr. Johnson's research program over the past fifteen months.
Dr. Johnson experienced a 12-week clinical research interruption because of COVID-19. The
University of Pennsylvania School of Medicine suspended all clinical research without a potential
direct impact on patient quantity of life (all observational clinical studies) in March 2020. Non-
essential research operations began in phases at limited capacity after Office of Research
Services approval in June 2020 — Dr. Johnson's resumed on-campus research operations in
September 2020. The university suspended all hiring in March 2020. The University of
Pennsylvania Interstitial Lung Disease (ILD) Program provides part-time clinical research
coordinator support to Dr. Johnson. The ILD program was hiring a new research coordinator prior
to the start of the COVID-19 pandemic. The interview and hiring process was suspended per the
university's guidelines, leaving Dr. Johnson without clinical research coordinator support for five
months.
Dr. Johnson experienced a 50% increase in clinical duties because of COVID-19. This involved
more clinical service time commitments, including unscheduled service time in the novel COVID
and traditional non-COVID intensive care units. Further, Dr. Johnson was on emergency jeopardy
coverage (on call at all times) for four months between March 2020 and July 2020.
Dr. Johnson was also subjected to increased childcare responsibilities. In March 2020 the daycare
centers for both of her children (ages 4 and 1) temporarily closed. Dr. Johnson did not hire a
caretaker to come into the home because of concerns about COVID-19 exposure. Dr. Johnson's
older child now attends public school in the city of Philadelphia. The Philadelphia School district
used a fully virtual (child learns at home remotely via synchronized online classes) model until
April 2021. In April 2021 the school district started a hybrid learning model (child attends school
in-person twice weekly with virtual learning the remaining three days a week) which continued
through the conclusion of the 2020-2021 school year. Dr. Johnson provided 95% of the in-home
learning support for her older child throughout the school year.
In summary, the COVID-19 pandemic due to increased clinical service time, university and health-
system-wide hiring freezes, restrictions on the conduct of research, and increased childcare
responsibilities negatively affected Dr. Johnson's research productivity.

## Key facts

- **NIH application ID:** 10448012
- **Project number:** 3K01HL135459-05S1
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** Cheilonda Johnson
- **Activity code:** K01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $70,470
- **Award type:** 3
- **Project period:** 2019-01-01 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10448012

## Citation

> US National Institutes of Health, RePORTER application 10448012, Determinants of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease. (3K01HL135459-05S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10448012. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*